Out of the Lab: Operationalizing Cell and Gene Therapy

In the competitive cell and gene therapy landscape, speed and efficiency are paramount. The biggest roadblock? The operational friction in tech transfer. This podcast is for executives focused on building a durable competitive advantage. We explore how to transform tech transfer from your biggest risk into your greatest asset. By solving the deep operational challenges and aligning perfectly with your CDMO partner, you can shorten timelines, protect capital, and get your therapy to patients faster. Move beyond day-to-day problems and learn to build a tech transfer strategy that wins.